ClinicalTrials.gg
Not yet recruitingNCT07721038Updated Jul 22, 2026

A Prospective Clinical Study Observed the Effects of Tubeless Anesthesia Method That Preserves Spontaneous Breathing and the Double-lumen Bronchial Intubation on the Brain Health During the Perioperative Period

An observational study in Brain Health, sponsored by Guangzhou Medical University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Guangzhou Medical University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This project conducts a prospective cohort study. By using multiple questionnaire survey methods such as the Pittsburgh Sleep Quality Index (PSQI) electronic wristband, QOR15, Pain Catastrophizing Scale (PCS), European Five-Dimensional Health Scale (EQ-5D), Revised American Pain Society Patient Follow-up Questionnaire (APS-POQ-R), Mini-Mental State Examination (MMSE), as well as perioperative stress and related indicators, hypothalamic-pituitary-adrenal axis (HPA) endocrine indicators, sublingual microcirculation, electroencephalogram, etc., comprehensive assessment is made of the correlations between the two different anesthesia methods of Tubeless retention of spontaneous breathing and double-lumen bronchial intubation and postoperative sleep, chronic pain and cognitive function, to construct a perioperative brain health safety system to improve prognosis; at the same time, optimize the perioperative sedation and analgesia plan and promote the postoperative brain health recovery of patients.

02

Conditions studied

  • Brain Health

Keywords

  • Tubeless anesthesia
  • double-lumen bronchial intubation
  • brain health
03

In context

Lead sponsor

Guangzhou Medical University is the lead sponsor of 40 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent elective non-anatomic partial lung resection surgery at the First Affiliated Hospital of Guangzhou Medical University

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient age: 18 - 75 years old
  • Patients meeting the standards of the (ASA) I-III grade and the (NYHA) I-II class
  • (BMI) \< 30 kg/m2
  • Intraoperative blood loss less than 300 ml
  • No severe cardiac or pulmonary dysfunction [first-second forced vital capacity (%) predicted value] > 50%, (EF) > 50%
  • No related to paravertebral nerve block and intercostal nerve block
  • Able to sign the form and possess communication, reading and writing abilities
  • Postoperative hospital stay of at least one day
  • No preoperative sleep disorders, no cognitive dysfunction (PSQI ≤ 10 points, PCS ≤ 38 points, > 27 points)

Exclusion criteria

Exclusion Criteria:

  • Already diagnosed with a mental disorder or had a preoperative (MMSE) score of less than 27
  • History of opioid abuse
  • Patients who were admitted to the ICU after surgery
  • Have severe cardiovascular, respiratory diseases
  • Experienced critical rescue during or after the surgery
  • Complicated with coagulation dysfunction, severe hypoxia or hypercapnia, or liver and kidney dysfunction
  • Difficult airway management
  • Changed anesthetic agent or surgical plan
  • Severe lacunar cerebral infarction, ischemic stroke or other neurological diseases
  • Changed anesthetic agent or surgical plan during the surgery;
Terms in these criteria, in plain language(8)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • tubeless group

    Patients undergoing elective non-anatomic partial lung resection surgery using the Tubeless technique for maintaining spontaneous breathing anesthesia

  • double-lumen bronchial intubation group

    Patients undergoing elective non-anatomic lung segmentectomy surgery using the double-lumen bronchial tube anesthesia method

06

What researchers measure

Primary outcomes

  1. Concentration of cognitive function biomarkers in the serum samples of 400 patients

    At time points T1, T2, and T3, 5 ml of peripheral venous blood was collected to test the biological indicators of postoperative cognitive function.

    Time frame: Before the start of the surgery (T1), at the end of the surgery (T2), and on the first day after the surgery (T3)

  2. Concentrations of HPA axis-related indicators in the serum samples of 400 patients

    At the TI-T2 time point, 5 ml of peripheral venous blood was collected for the detection of HPA axis-related indicators.

    Time frame: Before the start of the surgery (T1), at the end of the surgery (T2)

  3. The concentrations of laboratory test indicators in the serum samples of 400 patients

    Record the laboratory test indicators at time points T1 and T3

    Time frame: Before the start of the surgery (T1), and on the first day after the surgery (T3)

Secondary outcomes

  1. Anesthesia Record Form

    Record the vital signs at the T2 time point

    Time frame: at the end of the surgery (T2)

  2. Case information system collection

    Record the pulmonary function, chest X-ray or chest CT at time points T1 and T3

    Time frame: Before the start of the surgery (T1), and on the first day after the surgery (T3)

  3. Anesthesia Record Form

    Record the intraoperative conditions

    Time frame: During the operation

  4. Postoperative follow-up records

    Record the time of chest tube removal after surgery

    Time frame: through study completion, an average of 1 year

  5. Postoperative follow-up records

    the usage of postoperative analgesic drugs

    Time frame: through study completion, an average of 1 year

  6. Postoperative follow-up records

    the postoperative hospital stay

    Time frame: through study completion, an average of 1 year

  7. Postoperative follow-up records

    the total hospitalization cost

    Time frame: through study completion, an average of 1 year

Other outcomes

  1. Postoperative follow-up records

    Record the occurrence of adverse events during the perioperative period

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Patient clinical data

Supporting information: Clinical study report

Access criteria: The data can be obtained by email from Lan Lan (Email: lanlan@gzhmu.edu.cn) for clinical requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jul 2026; primary completion for Dec 2027, 17 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2026
First posted
Jul 22, 2026
StartEst.
Jul 20, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Jul 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07721038
Lead sponsor
Guangzhou Medical University
Responsible party
Fengfa Yang (Principal Investigator, Guangzhou Medical University) — Principal investigator
First posted
Jul 22, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 22, 2026

Study contacts

Lan Lan, PHD
Contact
lanlan@gzhmu.edu.cn
+8602083062566
Fengfa Yang, BS
Contact
yff18312377134@163.com
+8602083062566
Lan Lan, PHD
study director · The First Affiliated Hospital of Guangzhou Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion